Seroxo
1 known investors
Seroxo is an in-vitro diagnostics (IVD) company that develops the LIT, a patented 10-minute finger-prick blood test measuring real-time 3D neutrophil function. The test targets applications in cancer detection, sepsis, and emergency triage.
BiotechHealthtechMedical Devices
Investors · 1
Frequently asked questions
- What does Seroxo do?
- Seroxo is an in-vitro diagnostics (IVD) company that develops the LIT, a patented 10-minute finger-prick blood test measuring real-time 3D neutrophil function. The test targets applications in cancer detection, sepsis, and emergency triage.
- Who are Seroxo's investors?
- Seroxo's investors include JumpStart Equity.